Figure 1.

Duration of response by central radiology review (mRECIST 1.1) in patients with PDGFRA D842V mutation only (BLU-285-1101 study).

Note: Duration of response was defined as the time from first documented response (complete or partial response) to the date of first documented disease progression or death due to any cause, whichever came first. Patients without confirmed response were excluded from this analysis. Patients who were still in response at time of data cut-off were censored at their last valid assessment. The product-limit method was used to obtain Kaplan–Meier estimates of survival.

mRECIST, modified RECIST; PDGFRA, platelet-derived growth factor receptor alpha.